As of April 2024 Cocrystal Pharma has a market cap of $14.54 Million. This makes Cocrystal Pharma the world's 8057th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $14.54 M | -16.97% |
2023 | $17.52 M | 10.34% |
2022 | $15.87 M | -74.94% |
2021 | $63.35 M | -32.06% |
2020 | $93.24 M | 435.38% |
2019 | $17.41 M | -83.84% |
2018 | $0.10 B | -26% |
2017 | $0.14 B | -47.02% |
2016 | $0.27 B | -55.52% |
2015 | $0.61 B | 1101.25% |
2014 | $51.44 M | -29.45% |
2013 | $72.92 M | -64.47% |
2012 | $0.20 B | -18.13% |
2011 | $0.25 B | |
2009 | $3.95 M | 3.96% |
2008 | $3.8 M |
On Apr 17th, 2024 the market cap of Cocrystal Pharma was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $348.86 B | 2,397,831.51% | ๐บ๐ธ USA |
Merck MRK | $317.56 B | 2,182,704.00% | ๐บ๐ธ USA |
Nature's Sunshine Products NATR | $0.35 B | 2,333.15% | ๐บ๐ธ USA |
USANA USNA | $0.82 B | 5,588.09% | ๐บ๐ธ USA |